Previous 10 | Next 10 |
Stellar Biotechnologies (NASDAQ: SBOT ): Q2 GAAP EPS of -$0.31 misses by $0.05 . More news on: Stellar Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
LOS ANGELES , May 8, 2019 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy and immuno-oncology development pipelines, today reported financial results for the three and six months ended March 31, 2019...
Gainers: Globus Maritime (NASDAQ: GLBS ) +84% . Organogenesis Holdings (NASDAQ: ORGO ) +61% . Yatra Online (NASDAQ: YTRA ) +37% . Axovant Sciences (NASDAQ: AXGT ) +31% . Bio-Path Holdings (NASDAQ: BPTH ) +27% . Seres Therapeutics (NASDAQ: MCRB ) +27% . Phunware (NASDAQ: PHUN ) ...
AquaBounty Technologies (NASDAQ: AQB ) -23% . More news on: AquaBounty Technologies, Inc., The Boeing Company, Seelos Therapeutics, Inc., Stocks on the move, Read more ...
Stellar Biotechnologies (NASDAQ: SBOT ): Q1 GAAP EPS of -$0.26 misses by $0.03 . More news on: Stellar Biotechnologies Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
LOS ANGELES , Feb. 5, 2019 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy and immuno-oncology development pipelines, today reported financial results for the three months ended December 31, 2018 an...
LOS ANGELES , Oct. 31, 2018 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy and immuno-oncology development pipelines, announced today that Stellar President and CEO Frank R. Oakes will present...
Gainers: PRQR +62% . MNKD +33% . SBOT +19% . VCEL +18% . NSU +17% . SYBX +15% . CORV +15% . VRA +15% . MVIS +14% . IGC +13% . More news on: ProQR Therapeutics, MannKind Corporation, Stellar Biotechnologies Inc., Stocks on the move, , Read more ...
Nano cap Stellar Biotechnologies ( SBOT +11.4% ) is up on more than triple normal volume in response to its announcement of a contract with the U.S. National Institutes of Health (NIH) to supply its Stellar KLH protein for clinical studies. More news on: Stellar Biotechnologies Inc., H...
PRQR +66% on positive interim results from Phase 1/2 clinical trial of QR-110 in LCA10 patients. More news on: ProQR Therapeutics, Cronos Group, Inc., Nevsun Resources Ltd., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Stellar Biotechnologies Inc. Company Name:
SBOT Stock Symbol:
NASDAQ Market:
Stellar Biotechnologies Inc. Website:
Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV" PR Newswire SAN FRANCISCO , April 17, 2024 /PRNewswire/ -- Serve Robotics Inc. (the "Company" or "Serve"), a leading autono...
Serve Robotics Inc. Common Stock to Be Quoted on OTCQB Under Ticker Symbol "SBOT" PR Newswire SAN FRANCISCO , March 7, 2024 /PRNewswire/ -- Serve Robotics Inc. (the "Company" or "Serve"), a leading autonomous sidewalk delivery company, announces that ...
Edesa Biotech and Stellar Biotechnologies Complete Business Combination Canada NewsWire TORONTO, June 7, 2019 TORONTO , June 7, 2019 /CNW/ -- Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, today reported that the previously announced business combin...